Comparison of Cognitive Effects of Lamotrigine and Oxcarbazepine in Epilepsy Patients

참고문헌 (42)

1. "Sicuteri F. Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine. Headache 1980", pp.99~102
2. Guell A, "Bes A. Clinical value of a dopaminergic agonist administration in migraine patients. Headache 1983"
3. David J, "Rascol A. Does the piribedil test permit predicting the efficacy of domperidone in the treatment of migraine? Headache 1985", pp.332~333
4. Bes A, "Geraud G. Pharmacological exploration of dopamine hypersensitivity in migraine patients. Int J Clin Pharmacol Res 1986"
5. Welch KMA, "Brown E. Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 1990", pp.317~329
6. Fisher H, "A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series", 13, pp.119~122 (1995)
7. Emilien G, "receptors-physiological understanding to therapeutic intervention potential", 84, pp.133~156 (1999)
8. Mascia A, "Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data", 18, pp.174~182 (1998)
9. Cerbo R, "Dopamine hypersensitivity in migraine: role of the apomorphine test", 20, pp.36~41 (1997)
10. Sicuteri F. Dopamine, "the second putative protagonist in headache. Headache 1977", pp.129~131
11. Honkasalo ML, "Migraine and concomitant symptoms among 8167 adult twin pairs", 35, pp.70~78 (1995)
12. Larsson B, "Genetic influence in headaches: a Swedish twin study", 35, pp.513~519 (1995)
13. Russell MB, "Olesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia 1993", pp.245~248
14. Lachman HM, "Association of codon 108", 158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome, 1996, pp.67, 468~472
15. Strous RD, "Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia", 41, pp.493~495 (1997)
16. Syvanen AC, "Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S- COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland", 7, pp.65~71 (1997)
17. Daniels JK, "No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity", 153, pp.268~270 (1996)
18. Lachman HM, "Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders", 6, pp.243~250 (1996)
19. Papolos DF, "Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele", 3, pp.346~349 (1998)
20. Ermin Erdal M, "Significance of the catechol-O-methyltransferase gene polymorphism in migraine", 94, pp.193~196 (2001)
21. Headache classification subcommittee of the international headache society, "The international classification of headache disorders. 2nd Edn", 24(Suppl), pp.1~160
22. Peroutka SJ, "Dopamine and migraine", 49, pp.650~656 (1997)
23. Peroutka SJ, "Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles", 49, pp.201~206 (1997)
24. Del Zompo M, "Association between dopamine receptor genes and migraine without aura in a Sardinian sample", 51, pp.781~786 (1998)
25. Dichgans M, "The D2 receptor NcoI allele: absence of allelic association with migraine with aura", 51, pp.928~ (1998)
26. Lea RA, "Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine", 3, pp.35~40 (2000)
27. Shepherd AG, "Dopamine receptor genes and migraine with and without aura: an association study", 42, pp.346~351 (2002)
28. Mochi M, "A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes", 23, pp.301~305 (2003)
29. Filic V, "Monoamine oxidases A and B gene polymorphisms in migraine patients", 15, pp.149~153 (2005)
30. Marziniak M, "Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine", 111, pp.603~609 (2004)
31. Tiihonen J, "Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism", 4, pp.286~289 (1999)
32. Kauhanen J, "Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers", 24, pp.135~159 (2000)
33. Hallikainen T, "Lack of association between the functional variant of the catechol-O-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior", 96, pp.348~352 (2000)
34. Ishiguro H, "Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism", 9, pp.135~138 (1999)
35. Chudler EH, "The role of the basal ganglia in nociception and pain", 60, pp.3~38 (1995)
36. "Paalzow GH. L-dopa induces opposing effects on pain in intact rats SCH 23390 or alpha-methyl-DL- p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J Pharmacol Exp Ther 1992", pp.470~479
37. Silberstein SD, "Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial", 60, pp.315~321 (2003)
38. Wang SJ, "Droperidol treatment of status migrainosus and refractory migraine", 37, pp.377~382 (1997)
39. Hyde TM, "Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex", 24, pp.224~232 (1996)
40. Kohli JD, "Goldberg LI. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol 1983", pp.137~141
41. Pietrini U, "myth and facts about basilar artery migraine. In", pp.147~160 (1985)
42. Nakamura A, "Association between catechol-O-methyltransferase (COMT) polymorphism and severe alcoholic withdrawal symptoms in male Japanese alcoholics", 6, pp.233~238 (2001)

관련 논문AI추천